Honda Motor Posts 6-Fold Increase in 4Q Operating Profit of $1.96 Billion 
Amazon, Microsoft Boost French Tech Sector with Multibillion-Euro Investments 
Genesis Gains Ground in the Luxury Car Market 
BYD Europe Challenges Tesla, EU Giants; Stellantis Defends Italian Turf 
Sam Altman Denies New Search Engine; OpenAI Rumored for Voice AI Launch 
McDonald’s Philippines Targets Aggressive Expansion with 60 New Stores 
OpenAI's Sam Altman Proposes 'Universal Basic Compute' as AI Job Threat Looms 
WNBA Star A'ja Wilson to Launch Own Signature Nike Shoe 
Pfizer, AstraZeneca Bolster French Economy with Nearly $1 Billion Investment 
Apple Reportedly Inks Deal with Samsung for Foldable Displays, Hints at Future Products 
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots 
First Look: Tesla Cybertruck's New Tactical Grey Interior Spotted in Forum Images 
Sriracha Shortage Predicted as Huy Fong Foods Stops Production of Famous Chili Sauce 
South Korea, China's AliExpress, and Temu Forge Critical Safety Pact 
ANZ Bank Under Investigation for Government Bond Sale 
CARLSBAD, Calif., March 11, 2016 -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it will release fourth quarter and 2015 financial results after the close of trading on Tuesday, March 15, 2016. The Company’s management team will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET to discuss the financial results and recent business developments.
Individuals interested in listening to the conference call may do so by dialing (855) 542-4216 for domestic callers or (412) 455-6079 for international callers, using Conference ID: 48228586. To listen to the webcast, please visit the investor relations section of the SeaSpine website at www.seaspine.com.
A replay of the call will be available beginning March 15, 2016 at 4:30pm PT/7:30pm ET through midnight on March 16, 2016. To access the replay, dial (855) 859-2056 or (404) 537-3406 and reference Conference ID: 48228586. The webcast will also be available on the SeaSpine website for one month following the completion of the call.
About SeaSpine
SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine’s orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine’s spinal fusion hardware portfolio consists of an extensive line of products to facilitate spinal fusion in minimally invasive surgery (MIS), complex spine, deformity and degenerative procedures. Expertise in both orthobiologic sciences and spinal fusion hardware product development allows SeaSpine to offer our surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in over 30 countries worldwide.
Investor Relations Contact Lynn Pieper Lewis (415) 309-5999 [email protected]
